跳至主要内容
临床试验/ISRCTN24852890
ISRCTN24852890进行中(未招募)Unknown

Supporting Women with adhErence to hormonE Therapy following breast cancer (SWEET)

ewcastle upon Tyne Hospitals NHS Foundation Trust0 个研究点目标入组 1,460 人开始时间: 2023年8月2日最近更新:
适应症

试验速览

阶段
Unknown
状态
进行中(未招募)
发起方
入组人数
1,460

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
Female

入选标准

  • 1. Aged 18+ years
  • 3. Diagnosis of ER-positive invasive breast cancer, stages 1-3 and treated with curative intent
  • 4. Completed surgery for breast cancer
  • 5. Within 3 months of first oral AET prescription (tamoxifen or aromatase inhibitor) post breast cancer completion surgery
  • 6. Completed chemotherapy (if applicable)
  • 7. Able to access the internet
  • 8. Has an email address
  • 9. Are willing to use a support package with a web-based component

排除标准

  • 2. Evidence of metastatic disease i.e. stage 4 disease (M1 regardless of T and N status)
  • 3. Have cognitive impairment sufficient to preclude participation, as judged by the clinical team
  • 4. Had previous AET (for another breast cancer)
  • 5. Are unable to read and understand English

研究者

发起方
ewcastle upon Tyne Hospitals NHS Foundation Trust

相似试验